These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23763380)

  • 21. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.
    Ohira H; Tojo J; Shinzawa J; Suzuki T; Miyata M; Nishimaki T; Kasukawa R
    Fukushima J Med Sci; 1998 Dec; 44(2):83-92. PubMed ID: 10091380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
    Kamar N; Ribes D; Izopet J; Rostaing L
    Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.
    Saad Y; Ahmed A; Saleh DA; Doss W
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):920-5. PubMed ID: 23442415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases.
    Wei Q; Jiang Y; Xie J; Yang M; Zhang Y; Wu Z; Chen S; Liao Z; Lin Z; Gu J
    Clin Rheumatol; 2020 Aug; 39(8):2425-2432. PubMed ID: 32103375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and clinical significance of antinuclear antibody in hepatitis C virus infection.
    Peng YC; Hsieh SC; Yang DY; Tung CF; Hu WH; Huang WN; Chen GH
    J Clin Gastroenterol; 2001; 33(5):402-6. PubMed ID: 11606858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study.
    Gatselis NK; Georgiadou SP; Tassopoulos N; Zachou K; Liaskos C; Hatzakis A; Dalekos GN
    World J Gastroenterol; 2005 Jan; 11(4):482-7. PubMed ID: 15641130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical correlates of the "rods and rings" antinuclear antibody pattern.
    Climent J; Morandeira F; Castellote J; Xiol J; Niubó J; Calatayud L; Mestre M; Bas J
    Autoimmunity; 2016; 49(2):102-8. PubMed ID: 26699543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.
    Imai H; Nakano Y; Kiyosawa K; Tan EM
    Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of the antinuclear antibodies in chronic viral hepatitis B in children.
    Pop TL; Stefănescu A; Samaşca G; Miu N
    Clin Lab; 2014; 60(6):931-9. PubMed ID: 25016697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders.
    Gulli F; Basile U; Gragnani L; Fognani E; Napodano C; Colacicco L; Miele L; De Matthaeis N; Cattani P; Zignego AL; Rapaccini GL
    Dig Liver Dis; 2016 Aug; 48(8):927-33. PubMed ID: 27289333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective evaluation of "Rods and Rings" pattern detected in the anti-nuclear antibody (ANA) indirect immunofluorescence (IIF) test.
    İnal N; Kurumanastırlı B; Taşkınoğlu T; Duran AÇ; Togay A; Sarıgüzel FM; Kaşifoğlu N; Soylu M; Doğan Y; Us E; Sarıbaş Z; Kaklıkkaya N; Şener B
    Front Immunol; 2024; 15():1359030. PubMed ID: 38911869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection.
    de Castro GLC; da Silva Graça Amoras E; Araújo MS; da Silva Conde SRS; Bichara CDA; Queiroz MAF; Vallinoto ACR
    Eur J Med Res; 2022 Sep; 27(1):180. PubMed ID: 36114565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of autoimmune reactivity with hepatitis B and C virus (HBV and HCV) infection in histologically proven chronic liver diseases.
    Shantha S; Thyagarajan SP; Premavathy RK; Sukumar RG; Mohan KV; Palanisamy KR; Rajasambandam P
    Indian J Med Microbiol; 2002; 20(1):12-5. PubMed ID: 17657016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the Prevalence of Non-Organ-Specific Autoantibodies in Egyptian Patients with HCV.
    Emara M; Mohsen E; Shawky RM; El-Domany RA
    Immunol Invest; 2020 Aug; 49(6):676-686. PubMed ID: 31820668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy.
    Noda K; Enomoto N; Arai K; Masuda E; Yamada Y; Suzuki K; Tanaka M; Yoshihara H
    Scand J Gastroenterol; 1996 Jul; 31(7):716-22. PubMed ID: 8819224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.
    Gregorio GV; Pensati P; Iorio R; Vegnente A; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 1998 Jun; 112(3):471-6. PubMed ID: 9649217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The detection of anti-nuclear antibody and IL-21 in patients infected with hepatitis C virus].
    Zou M; Li MM; Huang SB; Li XJ; Zhou YP; Liu SW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):471-2. PubMed ID: 20423656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity of antinuclear antibody responses in hepatocellular carcinoma.
    Covini G; von Mühlen CA; Pacchetti S; Colombo M; Chan EK; Tan EM
    J Hepatol; 1997 Jun; 26(6):1255-65. PubMed ID: 9210612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.
    Keppeke GD; Satoh M; Ferraz ML; Chan EK; Andrade LE
    Immunol Res; 2014 Oct; 60(1):38-49. PubMed ID: 24845459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.